Lexicon Pharma (LXRX) Tops Q2 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. ABBV
5. CL
6. TFII
7. LYB
8. MRVL
9. NVT
10. SPY

Go back to Lexicon Pharma (LXRX) Tops Q2 EPS by 5c

JPMorgan Downgrades Lexicon Pharmaceuticals (LXRX) to Neutral

August 10, 2015 6:45 AM EDT

JPMorgan downgraded Lexicon Pharmaceuticals (NASDAQ: LXRX) from Overweight to Neutral with a price target of $14.00 (from $9.00).

For an analyst ratings summary and ratings history on Lexicon Pharmaceuticals click here. For more ratings news on Lexicon Pharmaceuticals click here.

Shares of Lexicon Pharmaceuticals closed at $11.38 yesterday.

... More